Download PDF
Ernährung & Medizin 2017; 32(04): 158-162
DOI: 10.1055/s-0043-121759
wissen
Haug Verlag in Georg Thieme Verlag KG Stuttgart

Jod und Selen – Bedeutung für die Funktion der Schilddrüse

Roland Gärtner
Medizinische Klinik IV der Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
19 December 2017 (online)

    Permissions and Reprints

Zusammenfassung

Die Schilddrüse ist das Organ mit dem höchsten Jod- und Selengehalt. Über mehr als 100 Jahre wurde Jodmangel als einzige Ursache der typischen Schilddrüsenerkrankungen angesehen. Hingegen hat man einen Selenmangel bisher üblicherweise nicht mit Erkrankungen der Schilddrüse in Verbindung gebracht. In den letzten Jahren hat sich aber gezeigt, dass Selenmangel wahrscheinlich entscheidender ist als Jod für die Entstehung der so häufigen Autoimmunthyreoiditis und auch der Neoplasien. Etwa 1 von 7 Menschen weltweit leiden an einem Selenmangel – ebenso viele wie an einem Jodmangel. In Deutschland und vielen europäischen Ländern ist etwa ein Drittel der Bevölkerung betroffen.

 

  • Literatur

  • 1 Kieliszek M, Blazejak S. Current knowledge on the importance of selenium in food for living organisms: a review. Molecules 2016; 21: 1-16
    Google Scholar
  • 2 Asvold BO, Vatten LJ, Midthjell K, Bjoro T. Serum TSH within the normal range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway. J Clin Endocrinol 2012; 97: 93-99
    CrossrefPubMedGoogle Scholar
  • 3 Bleys J, Navas-Acien A, Guallar E. Serum selenium levels and all-cause cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008; 168: 404-410
    CrossrefPubMedGoogle Scholar
  • 4 Akbaraly TN, Arnaud J, Hininger-Favier I. et al. Selenium and mortality in the elderly: results from the EVA study. Clin Chem 2005; 51: 2117-2223
    CrossrefPubMedGoogle Scholar
  • 5 Xue H, Wang W, Li Y. et al. Selenium upregulates CD4+CD25+ regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2h4 mice. Endocrine J 2010; 57: 595-601
    CrossrefPubMedGoogle Scholar
  • 6 Köhrle J, Jakob F, Contempre B. et al. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005; 26: 944-984
    CrossrefPubMedGoogle Scholar
  • 7 Hu S, Rayman MP. Multiple nutritional factors and the risk of Hashimoto’s thyroiditis. Thyroid 2017; 27: 597-610
    CrossrefPubMedGoogle Scholar
  • 8 Zimmermann MB. Iodine deficiency in industrialised countries. Proc Nutr Soc 2010; 69: 133-143
    CrossrefPubMedGoogle Scholar
  • 9 Gärtner R, Dugrillon A. Vom Jodmangel zur Struma. Pathophysiologie der Jodmangelstruma Internist 1998; 39: 566-573
    PubMedGoogle Scholar
  • 10 Völzke H, Friedrich N, Schipf S. et al. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab 2007; 92: 4039-4045
    CrossrefPubMedGoogle Scholar
  • 11 Stübner D, Gärtner R, Greil W. et al. Hypertrophy and hyperplasia during goiter growth and involution in rats. Separate bioeffect of TSH and iodine. Acta Endocrinol 1987; 116: 537-548
    PubMedGoogle Scholar
  • 12 Morgan SJ, Neumann S, Marcus-Samuels B, Gershengorn MC. Thyrotropin stimulates differentiation not proliferation of normal human thyrocytes in culture. Frontiers in Endocrinology 2016; 7: 1-4
    PubMedGoogle Scholar
  • 13 Ock S, Ahn J, Lee SH. et al. IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter. FASEB J 2017; 27: 4899-4908
    PubMedGoogle Scholar
  • 14 Greil W, Rafferzeder M, Bechtner G, Gärtner R. Release of an endothelial cell growth factor from cultured porcine thyroid follicles. Molecular Endocrinol 1989; 3: 858-867
    CrossrefPubMedGoogle Scholar
  • 15 Gärtner R, Pisarev MA. Thyroid Autoregulation. In: Braverman LE, Utiger RD. eds. Werner and Ingbar’s the thyroid. 8th ed. Baltimore: Lippincott Williams & Wilkins; 2000: 85-90
    Google Scholar
  • 16 Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 815-827
    CrossrefPubMedGoogle Scholar
  • 17 Kryukov GV, Gladyshev VN. Mammalian selenoprotein gene signature: identification and functional analysis of selenoprotein genes using bioinformatics methods. Methods Enzymol 2002; 347: 84-100
    PubMedGoogle Scholar
  • 18 Schmutzler C, Mentrup B, Schomburg L. et al. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 2007; 388: 1053-1059
    PubMedGoogle Scholar
  • 19 Ventura M, Melo M, Carrilho F. Selenium and thyroid diseases: From pathophysiology to treatment. International J Endocrinol 2017; 1-9
    PubMedGoogle Scholar
  • 20 Rasmussen LB, Schomburg L, Köhrle J. et al. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 2011; 164: 585-590
    CrossrefPubMedGoogle Scholar
  • 21 Wu Q, Rayman MP, Lv H. et al. Low population selenium status is associated with increased prevalence of thyroid diseases. J Endocrinol Metab 2015; 100: 4037-4047
    CrossrefPubMedGoogle Scholar
  • 22 Derumeaux H, Valeix P, Castetbon K. et al. Association of selenium with thyroid volume and echostructure in 35- to 60-Year-old French adults. Eur J Endocrinol 2003; 48: 309-315
    PubMedGoogle Scholar
  • 23 Gärtner R, Gasnier BC, Dietrich JW. et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 2002; 87: 1687-1691
    CrossrefPubMedGoogle Scholar
  • 24 Wichmann J, Winther KH, Bonnema SJ, Hegedüs L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systemic review and meta-analysis. Thyroid 2016; 26: 1681-1692
    CrossrefPubMedGoogle Scholar
  • 25 Negro R, Greco G, Mangieri T. et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92: 1263-1268
    CrossrefPubMedGoogle Scholar
  • 26 Marcocci C, Kahaly GJ, Krassas GE. et al. Selenium and the course of mild Graves‘ orbitopathy. N Engl J Med 2011; 364: 1920-1931
    CrossrefPubMedGoogle Scholar
  • 27 Faure P, Ramon O, Favier A. et al. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 2004; 34: 475-481
    CrossrefPubMedGoogle Scholar
  • 28 Kipp AP, Strohm D, Brigelius-Flohe R. et al. Revised reference values for selenium intake. J Trace Element in Med Biol 2015; 32: 195-199
    PubMedGoogle Scholar
  • 29 Rayman MP. Selenium and human health. Lancet 2012; 379: 1256-1268
    CrossrefPubMedGoogle Scholar